 |
This Congress has been declared free of tobacco smoke |
 |
Buenos Aires, Capital of Book 2011 |
 |
 |
| Official Domestic Carrier | Official International Carrier |
 |
MCI Buenos Aires Avenida Santa Fe 1970, 1º Piso, Oficina 1 C1123AAO, Buenos Aires, Argentina Phone: +54 11 5252 9801 / Fax: +54 11 4813 0073 e-mail - Web |
EspañolWednesday, September 21
| 9.00-10.30 | Core Symposium CS10 |
PHARMACOTHERAPIES IN PSYCHIATRY: OUR HERITAGE AND OUR FUTURE
Chairperson: H.-J. Möller (Germany)
CS10.1 Current state and future perspectives of the use of antipsychotics
H.-J. Möller (Germany)
CS10.2 Current status and future perspectives of the use of antidepressants
G. Papakostas (USA)
CS10.3 Current state and future perspectives of the use of mood stabilizers
S. Kasper (Austria)
| 9.00-10.30 | Core Symposium CS11 |
PROMOTION OF MENTAL HEALTH AND PREVENTION OF MENTAL DISORDERS
Chairperson: P. Cuijpers (The Netherlands)
CS11.1 Promotion of mental health: can Europe show the way to the world?
K. Wahlbeck (Finland)
CS11.2 Prevention of suicide worldwide: an overview
Z. Rihmer (Hungary)
CS11.3 Preventing the onset of depressive disorders: possibilities and challenges
P. Cuijpers (The Netherlands)
| 9.00-10.30 | SPECIAL LECTURES |
Chairperson: S. Tyano (Israel)
SL3 Theories of mental symptom formation: history and epistemology
G.E. Berrios (UK)
SL4 The psychoses of childbearing
I. Brockington (UK)
| 9.00-10.30 | Regular Symposium RS51 |
DEVELOPMENTS IN THE CLASSIFICATION OF PERSONALITY DISORDER
Chairperson: N. Koldobsky (Argentina)
RS51.1 The central domains of personality pathology in psychiatric patients
R. Mulder (New Zealand)
RS51.2 Classifying personality disorder according to severity
M. Crawford (UK)
RS51.3 Proposed changes to the classification of personality disorder in DSM-5
A. Skodol (USA)
RS51.4 Preliminary findings from field trials of ICD-11
P. Tyrer (UK)
| 9.00-10.30 | Regular Symposium RS52 |
BIPOLAR DISORDER: IDENTIFICATION AND HEALTH CARE UTILIZATION PATTERNS
Chairperson: M. Frye (USA)
RS52.1 Direct costs of bipolar disorder compared to other chronic conditions: an employer-based health plan analysis
M. Frye, M. Williams, N. Shah, A. Wagie, D. Wood (USA)
RS52.2 Screening and identifying bipolar disorder in primary care: can it impact health care utilization patterns?
M. Williams, N. Shah, A. Wagie, D. Wood, M. Frye (USA)
RS52.3 Feasibility of one-day training programs in bipolar disorder detection for general practitioners and clinical psychologists
S. Strejilevich (Argentina)
RS52.4 Mood state and reproductive health in bipolar women
E. Marengo (Argentina)
Discussant: R. Alarcón (USA)
| 9.00-10.30 | Regular Symposium RS53 |
NEW CHALLENGES AND NEW SOLUTIONS FOR EARLY CAREER PSYCHIATRISTS: THE ROLE OF THE WPA (organized by the WPA Early Career Psychiatrists Council)
Chairpersons: A. Fiorillo (Italy), F. Picon (Brazil)
RS53.1 Contemporary psychiatric training around the world
F. Picon, H. Elkholy, A. Fiorillo, Z. Lattova (Brazil/Egypt/Italy/Czech Republic)
RS53.2 Early career psychiatrists in Africa and Middle East: training and unmet needs
H. Elkholy (Egypt)
RS53.3 Training in psychiatry in Central and Eastern European countries
Z. Lattova (Czech Republic)
RS53.4 The evolving role of young psychiatrists: an Australasian perspective
P. Brahmbhatt (Australia)
RS53.5 The WPA initiatives for early career psychiatrists
A. Fiorillo, Z. Lattova, P. Brahmbhatt, H. Elkholy, F. Picon (Italy/Czech Republic/Australia/Egypt/Brazil)
| 9.00-10.30 | Workshop WO9 |
PSYCHODYNAMIC APPROACHES TO EATING DISORDERS: AN UPDATE
G. Onofrio, V. Ems, M. Sanguesa, M. Botbol, M. Robin, M. Corcos, M.A. Nunes (Argentina/Uruguay/Chile/France/Brazil)
| 9.00-10.30 | Section Symposium SS28 |
BRAIN MODULES AND THE SCHIZOPHRENIA SPECTRUM
(organized by the WPA Sections on Schizophrenia and on Clinical Psychopathology)
Chairpersons: W. Gaebel (Germany), S. Galderisi (Italy)
SS28.1 A modular concept of psychopathology in schizophrenia and other psychoses
W. Gaebel (Germany)
SS28.2 The positive symptoms module in schizophrenia
A. Abi-Dargham (USA)
SS28.3 Negative symptoms of schizophrenia: do we know the underlying brain circuitry?
S. Galderisi (Italy)
SS28.4 Thought disorders as a disorder of the language system
W. Strik, H. Horn (Switzerland)
| 9.00-10.30 | Section Symposium SS29 |
EPILEPTIFORM PROCESSES AND ANTICONVULSANTS IN PSYCHIATRIC PATIENTS (organized by the WPA Section on Psychophysiology in Psychiatry)
Chairpersons: J. Raboch (Czech Republic), N. Boutros (USA)
SS29.1 Scalp recording of epileptic discharges in psychiatric patients: tip of the iceberg problem
N. Boutros (USA)
SS29.2 Anticonvulsant treatment and epileptiform changes in unipolar depressive patients
P. Bob, J. Raboch (Czech Republic)
SS29.3 Focal QEEG findings in patients with psychiatric presentations: establishment of personalized treatment
L.M. Konopka, E. Zimmerman (USA)
SS29.4 Localization of interictal epileptiform activity with combined EEG and fMRI
T. Koenig, M. Hauf, R. Wiest, K. Jann, T. Dierks (Switzerland)
| 9.00-10.30 | Section Symposium SS30 |
WHY AND HOW WE PSYCHIATRISTS NEED FAMILY ORIENTED SKILLS FOR OUR SURVIVAL? (organized by the WPA Section on Family Research and Intervention)
Chairperson: T. Kurimay (Hungary)
SS30.1 Family functioning in the community
G. Keitner (USA)
SS30.2 Expressed emotion and substance-related disorders in outpatient and residential treatment: an exploratory study
G. Carrà, P. Sciarini, M. Clerici (Italy/UK)
SS30.3 Representation of the therapeutic relationship among Hungarian psychiatric residents
E. Fülöp, M. Csabai, T. Kurimay (Hungary)
SS30.4 How to empower psychiatrists to work with patients and their families?
A. Wilson (UK)
| 9.00-10.30 | Section Symposium SS31 |
SOCIAL DETERMINANTS OF HEALTH ARE CRITICAL TO WOMEN’S MENTAL HEALTH (organized by the WPA Section on Women's Mental Health)
Chairpersons: U. Niaz (Pakistan), E. Levin (Argentina)
SS31.1 The impact of access to education on women’s mental health
M.B. Rondon (Peru)
SS31.2 Violence against women and mental health
D.E. Stewart (Canada)
SS31.3 Poverty, a major social determinant in women’s mental health
U. Niaz (Pakistan)
| 9.00-10.30 | Simposio Regular RSp/e33 |
LAS ALUCINACIONES: SU OBJETO, MUNDO Y VALOR SINTOMATOLOGICO
Presidente: J. Garrabé (Francia)
RSp/e33.1 Las alucinaciones: ¿pueden ser representadas? De las realizaciones
plásticas de H. Michaud a las imágenes del PET-SCAN
P. Belzeaux (Francia)
RSp/e33.2 Eidolias alucinósicas visuales, oftalmopatías y síndrome de
Charles Bonnet
P. Chenivesse, M. De Luca (Francia)
RSp/e33.3 La alucinación: del evento a la ideología: Ey con Badiou
T.E. Mahieu (Francia)
RSp/e33.4 Significado del “sindrome de síntomas psicóticos atenuados” (DSM-5)
H. Casarotti (Uruguay)
| 9.00-10.30 | Simposio Regular RSp/e34 |
O ESTRESSE, CATASTROFES NATURAIS E OS TRASTORNOS MENTAIS RECORRENTES
Presidente: M.F. Juruena (Brasil)
RSp/e34.1 “Síndrome do coração partido” e estresse pós-traumático
V. Lemgruber (Brasil)
RSp/e34.2 Catastrofes naturais e suas repercussões em saúde mental
F. Vasconcellos (Brasil)
RSp/e34.3 O estresse precoce e os transtornos mentais recorrentes
M.F. Juruena (Brasil)
| 9.00-10.30 | Workshop WOp/e13 |
PSICOANALISIS, SUBJETIVIDAD Y COMUNIDAD: NUESTRO LEGADO Y NUESTRO FUTURO
L. Ricon, M. Viñar (Argentina/Uruguay)
| 9.00-10.30 | Workshop WOp/e14 |
EL USO DE LAS CLASIFICACIONES EN PSIQUIATRÍA Y SUS CONSECUENCIAS EN LA SALUD PÚBLICA
C. Hacker, S. Levín, G. Rossi, E. Vaschetto (Argentina)
| 10.45-12.15 | KEYNOTE LECTURES |
Chairperson: J.A. Costa e Silva (Brazil)
KL13 Schizophrenia: the beginning, the change, the future
W.T. Carpenter Jr. (USA)
KL14 Clinical approach to bipolar disorder
E. Vieta (Spain)
| 10.45-12.15 | Regular Symposium RS54 |
CURRENT RESEARCH ON THE INDIVIDUAL PLACEMENT AND SUPPORT (IPS) MODEL OF SUPPORTED EMPLOYMENT
Chairperson: T. Burns (UK)
RS54.1 The implementation of individual placement and support in Europe
T. Burns (UK)
RS54.2 Costs and cost-effectiveness of the individual placement and support model of supported employment: a review of the literature
E. Latimer (Canada)
RS54.3 Individual placement and support and first episode psychosis
S. Singh, M. Rinaldi, R. Perkins, K. McNeil, N. Hickman, F. Jonsson (UK)
RS54.4 The Social Security Administration's Mental Health Treatment Study
R. Drake (USA)
| 10.45-12.15 | Regular Symposium RS55 |
IMPROVING EFFICACY AND TOLERABILITY OF ANTIDEPRESSANTS IN CLINICAL PRACTICE
Chairperson: P. Blier (Canada)
RS55.1 Combination of antidepressants from treatment initiation: new treatment strategy in clinical practice?
P. Blier (Canada)
RS55.2 The role of pharmacogenetics in the efficacy and tolerability of antidepressants
A. Schosser (Austria)
RS55.3 Safety of amisulpride in combination with antidepressants in common clinical practice
E. Ceskova, J. Suchopar, Z. Priborska (Czech Republic)
RS55.4 Drug surveillance and safety in German-speaking hospital care
S. Kasper, A. Konstantinidis (Austria)
| 10.45-12.15 | Regular Symposium RS56 |
IMPULSIVITY AND BRAIN FUNCTION IN ADDICTIONS
Chairperson: F.G. Moeller (USA)
RS56.1 White matter and impulsivity in drug addiction
F.G. Moeller, J.L. Steinberg, S.D. Lane, L.A. Kramer, N. Rathnayaka, P.A. Narayana (USA)
RS56.2 Neither bipolar nor obsessive-compulsive: pathological buyers are impulsive acquirers
H. Tavares, T.Z. Filomensky (Brazil)
RS56.3 Impulsivity in non-substance and substance addictions
M.N. Potenza (USA)
RS56.4 Cocaine use affects brain myelin
P.A. Narayana, J. Herrera. J.L. Steinberg, F.G. Moeller (USA)
| 10.45-12.15 | Regular Symposium RS57 |
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: DIAGNOSIS AND TREATMENT ACROSS THE LIFESPAN
Chairperson: F. Macciardi (Italy/USA)
RS57.1 Diagnostic strategies for attention-deficit/hyperactivity disorder
F.X. Castellanos (USA)
RS57.2 Dysfunction in cognition and executive function in attention deficit/hyperactivity disorder
M. Battaglia (Italy)
RS57.3 Short-term successes and long-term challenges in treatment of attention deficit/hyperactivity disorder
L. Greenhill (USA)
| 10.45-12.15 | Regular Symposium RS58 |
PREDICTING FEAR CONDITIONING AND ITS EXTINCTION FROM BIOLOGICAL AND PSYCHOLOGICAL MEASURES
Chairperson: G.J. Quirk (Puerto Rico)
RS58.1 Prefrontal-amygdala circuits mediating extinction of fear
G.J. Quirk (Puerto Rico)
RS58.2 Genetics of fear extinction: a novel mouse model
A. Holmes (USA)
RS58.3 Functional reactivity of the fear extinction network to safe stimuli may be predicted by its resting metabolic activity in the human brain
M.R. Milad (USA)
RS58.4 Neuropsychological tests as predictors of fear conditioning and extinction
K.G. Martinez (Puerto Rico)
| 10.45-12.15 | Workshop WO10 |
MONITORING HUMAN RIGHTS IN MENTAL HEALTH INSTITUTIONS: THE ITHACA TOOLKIT
G. Thornicroft, L. Burti, H. Katschnig, O. Lewis, D. Rose, K. Wahlbeck, G. Hagmair(UK/Italy/Austria/Hungary/Finland), and the ITHACA Project Group
| 10.45-12.15 | Section Symposium SS32 |
CROSS-NATIONAL MENTAL HEALTH RESEARCH: NATIONAL BENEFITS (organized by the WPA Section on Epidemiology and Public Health)
Chairperson: V. Kovess (France)
SS32.1 Women across Europe: similarities and differences
V. Kovess, S. Van der Velde, A. Boyd (France)
SS32.2 Making research serve policy formulation
O. Gureje (Nigeria)
SS32.3 Translating large, population-based data into mental health policy development and service implementation: the case of Colombia
S. Aguilar-Gaxiola, J. Posada-Villa (USA/Colombia)
SS32.4 Mental health research in Lebanon: towards a policy
E.G. Karam (Lebanon)
Discussant: G. de Girolamo (Italy)
| 10.45-12.15 | Section Symposium SS33 |
CONTEXTS OF CREATIVITY: LITERATURE, ART AND MENTAL HEALTH (organized by the WPA Sections on Literature and Mental Health and on Art and Psychiatry)
Chairperson: A. Mohit (Iran)
SS33.1 Literature as one of the main guides to psychiatric symptomatology
A. Mohit (Iran)
SS33.2 Brain and society
H. Thomashoff (Austria)
SS33.3 Borges and the stethoscope
B. Cardoso (Brazil)
SS33.4 Psychopathology in Shakespeare’s Macbeth
S. Karaoulanis (Greece)
SS33.5 Creativity and Asperger syndrome
S. Kato (Japan)
SS33.6 The great divide 2.0? The case for liberal arts in health science curricula
E. Sukhanova (USA)
| 10.45-12.15 | Section Symposium SS34 |
THE IMPACT OF SPIRITUALITY ON CONFLICT MANAGEMENT AND RESOLUTION (organized by the WPA Sections on Religion, Spirituality and Psychiatry, and on Conflict Management and Resolution)
Chairpersons: P.J. Verhagen (The Netherlands), M. Sadre-Chirazi-Stark (Germany)
SS34.1 Spirituality, traditional healing and mental health care in the Caribbean
F.W. Hickling (Jamaica)
SS34.2 Spirituality, violence, conflict resolution
P.J. Verhagen (The Netherlands)
SS34.3 Secular perspectives in India, a Hindu majority country
R.A. Kallivayalil (India)
SS34.4 Psychiatry and mental health in the 21st century: we need humanities in forms of spirituality and literature to help us overcome the challenges
A. Mohit (Iran)
Discussant: E. Sorel (USA)
| 10.45-12.15 | Section Symposium SS35 |
PREVENTING SUICIDE IN OLD AGE (organized by the WPA Sections on Old Age Psychiatry and on Suicidology)
Chairpersons: C.A. de Mendonça Lima (Portugal), J.P. Soubrier (France)
SS35.1 Suicide prevention in old age: national strategies
J.P. Soubrier (France)
SS35.2 Suicide in old age in Portugal: facts and figures
C.A. de Mendonça Lima, R.M. Rodrigues (Portugal)
SS35.3 Suicide by intoxication of older persons in Brazil: data from the SINITOX 1999-2008
R. Bochner, C. Estellita-Lins, M. Bteshe (Brazil)
SS35.4 Indirect self-destructive behaviors in the elderly: how to assess and manage them?
V. Camus (France)
| 10.45-12.15 | Section Workshop SW2 |
TRAINING IN PSYCHOANALYTICAL PSYCHOTHERAPY FOR CLINICIANS (organized by the WPA Section on Psychoanalysis in Psychiatry)
M. Botbol, P. Giannakopoulos, A. Levin, P. Rey-Bellet, M. Favelukes (France/Switzerland/Argentina)
| 10.45-12.15 | Simposio Regular RSp/e35 |
CONTROVERSIAS SOBRE LA AGRESIVIDAD Y LA VIOLENCIA EN PSIQUATRIA: ASPECTOS GENÉTICOS, CLÍNICOS, ETICOS Y LEGALES
Presidente: E. Toro-Martínez (Argentina)
RSp/e35.1 Controversias acerca del concepto de peligrosidad en psiquiatría y
medicina forense
E. Toro-Martínez (Argentina)
RSp/e35.2 Violencia: la agresión humana como una conducta biológicamente
determinada y psicosocialmente modulada
E. Rubio (Argentina)
RSp/e35.3 Genética del comportamiento antisocial
A. Corrales (Argentina)
RSp/e35.4 Bases neuropsicobiológicas de la violencia en el adolescente
P. Chieri (Argentina)
| 10.45-12.15 | Simposio Regular RSp/e36 |
ASPECTOS FILOSÓFICOS Y EPISTEMOLÓGICOS DE LA PSICOFARMACOLOGÍA
Presidente: J.C. Stagnaro (Argentina)
RSp/e36.1 Aspectos filosóficos de la psicofarmacología I
S. Halsband (Argentina)
RSp/e36.2 Aspectos filosóficos de la psicofarmacología II
C. Lamela (Argentina)
RSp/e36.3 Implicancias éticas en la práctica psicofarmacológica
D. Lagos (Argentina)
| 10.45-12.15 | Simposio Regular RSp/e37 |
SALUD MENTAL Y PREJUICIO
Presidente: M.A. Materazzi (Argentina)
RSp/e37.1 Información y prejuicio en salud mental
M. De Berardinis (Italia)
RSp/e37.2 Análisis del prejuicio desde la perspectiva psicodinámica
F. Materazzi (Argentina)
RSp/e37.3 Viejos y nuevos prejuicios respecto a la salud mental desde la
experiencia de 25 años de reforma psiquiátrica y de atención a la
salud mental en España
M. Hernández Monsalve (España)
RSp/e37.4 Evaluación del prejuicio en un centro de emergencia situado en
San Antonio, Texas
P. Ruggero (USA)
RSp/e37.5 Multitud: concepto - herramienta para la construcción de una sociedad
que pueda retomar su entramado
E. Cohen (Argentina)
| 10.45-12.15 | Simposio Regular RSp/e38 |
ACTUALIZACION CLINICA Y TERAPEUTICA DE LOS TRASTORNOS DEL ÁNIMO
Presidente: O. Olego (Argentina)
RSp/e38.1 Introducción general
O. Olego (Argentina)
RSp/e38.2 Depresión bipolar: tratamiento psicofarmacológico
G. Dorado (Argentina)
RSp/e38.3 Nuevas experiencias en el tratamiento farmacológico de comorbilidad
entre patología bipolar y adicciones
E. Kalina (Argentina)
RSp/e38.4 Diferencias clínicas y pronósticas entre los trastornos bipolares, la
esquizofrenia y los trastornos esquizoafectivos
A. Benabarre (Argentina)
| 12.30-14.30 | Oral Communication Sessions OC13 |
DYNAMIC PSYCHIATRY AND PSYCHOSOCIAL INTERVENTIONS (I)
| 12.30-14.30 | Oral Communication Sessions OC14 |
SOCIAL PSYCHIATRY (II)
| 12.30-14.30 | Oral Communication Sessions OC15 |
CHILD AND ADOLESCENT PSYCHIATRY (I)
| 12.30-14.30 | Oral Communication Sessions OC16 |
HOSPITAL AND COMMUNITY CARE (II)
| 12.30-14.30 | Oral Communication Sessions OC17 |
TRAUMA AND RESILIENCE
| 12.30-14.30 | Oral Communication Sessions OC18 |
PSYCHIATRY AND GENERAL MEDICINE (II)
| 12.30-14.30 | Poster Session PO4 |
HOSPITAL AND COMMUNITY CARE
| 12.30-14.30 | Sponsored Symposium SPE7 |
WHEN TREATMENT FAILS: THE ROLE OF ATYPICAL ANTIPSYCHOTICS IN MAJOR
DEPRESSIVE DISORDER (Organized by AstraZeneca)
Chairperson: M. Tohen (USA)
SPE7.1 When treatment fails: augmentation with atypical antipsychotics in
major depressive disorder
H. Eriksson (Sweden)
SPE7.2 Targeting symptomatic control and functional recovery in patients with
major depressive disorder
P. Gorwood (France)
SPE7.3 The challenge of the complex patient
R. McIntyre (Canada)
| 12.30-14.30 | Sponsored Symposium SPE8 |
MAJOR DEPRESSION: OUR HERITAGE AND OUR FUTURE (Organized by Eli Lilly & Company)
Chairperson: A. Lopez Mato (Argentina)
SPE8.1 The heritage of major depression: past treatments, stigma, and impact
N. Sartorius (Switzerland)
SPE8.2 The future is the future: neurobiology and genetics
F. Kapczinski (Brazil)
SPE8.3 The future is now: individualized patients outcomes
S. Kennedy (Canada)
Discussant: J.M. Menchón (Spain)
| 12.30-13.30 | Meet the Expert Session MTE2 |
SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS AS FIRST LINE
TREATMENT (I) (Organized by Pfizer)
MTE2.1 Serotonin-norepinephrine reuptake inhibitors as first line treatment:
relapse and remission
J. Rakesh (USA)
| 13.30-14.30 | Meet the Expert Session MTE3 |
SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS AS FIRST LINE
TREATMENT (II) (Organized by Pfizer)
MTE3.1 Serotonin-norepinephrine reuptake inhibitors as first line treatment:
drug to drug interactions
M. Thase (USA)
| 12.30-13.30 | Simposio Regular RSp/e39 |
RESPONSABILIDADES E LIMITES TÉCNICOS PARA O EXERCÍCIO DA PSIQUIATRIA FORENSE
Presidente: A.M.A.S. Meleiro (Brasil)
RSp/e39.1 Pedofilia: a vítima e suas consequências
A.M.A.S. Meleiro (Brasil)
RSp/e39.2 Responsabilidade penal e dependência química
V.S. Ikuhara (Brasil)
RSp/e39.3 Avaliação do risco de violência em psiquiatria forense
E. Abdalla-Filho (Brasil)
| 12.30-13.30 | Workshop WOp/e15 |
AUTISMO Y TDAH: DE LA NIÑEZ A LA ADULTEZ. EXPERIENCIAS CUBANAS
T.A. Peón Valdés, A. Duany Navarro, M. Whilby Santiesteban, J.J. Peláez Capó (Cuba)
| 13.30-14.30 | Workshop WOp/e16 |
¿NUEVAS REALIDADES, IDENTIDADES Y SEXUALIDADES? ACTUALIZACIÓN SOBRE TRANSEXUALISMO
S. Griselli, C. Tavani, A. Apice Vidal, R. De Santos, M. Bascans (Argentina)
| 13.30-14.30 | Simposio Regular RSp/e40 |
LA IMPORTANCIA DE LOS BIOMARCADORES, LA PREVENCION Y LA VIOLENCIA
Presidente: M.C. Scheerle (Argentina)
RSp/e40.1 Trastorno de ansiedad: una mirada desde la óptica de los
biomarcadores
P. Pascual (Rep. Dominicana)
RSp/e40.2 La importancia del acido kinurenico como biomarcador en las
esquizofrenias
C.I. Benavente Pinto (Argentina)
RSp/e40.3 Marcadores biológicos en el trastorno bipolar
E. Camarena Robles (Méjico)
RSp/e40.4 La violencia y la psiquiatría. Violencia y prevención: un programa en
acción
M. Adad (Brasil)
|
14.45-16.15 |
KEYNOTE LECTURES |
Chairperson: A. Cia (Argentina)
KL15 Clinical approach to major depression
M.E. Thase (USA)
KL16 Anxiety disorders: an integrative approach
D.J. Stein (South Africa)
| 14.45-16.15 | Regular Symposium RS59 |
DISSEMINATION OF THE INDIVIDUAL PLACEMENT AND SUPPORT (IPS) MODEL OF SUPPORTED EMPLOYMENT
Chairperson: R. Drake (USA)
RS59.1 Dissemination of individual placement and support in Italy: problems and opportunities
A. Fioritti, R. Sabatelli, D. Manchisi, D. Piegari, N. Dell'Alba, V. Trono (Italy)
RS59.2 Individual placement and support research and development in early psychosis in Australia
E. Killackey (Australia)
RS59.3 Individual placement and support model of supported employment in the United States
D. Becker (USA)
RS59.4 Individual placement and support in the UK
B. Grove (UK)
| 14.45-16.15 | Regular Symposium RS60 |
RELIGION, SPIRITUALITY AND PSYCHIATRY
Chairperson: P.J. Verhagen (The Netherlands)
RS60.1 Religious and non-religious worldviews
P.J. Verhagen (The Netherlands)
RS60.2 Differential diagnosis between spiritual experiences and mental disorders
A. Moreira-Almeida, A. Menezes Jr. (Brazil)
RS60.3 Twelve year history of depression, image of God and religious coping: results from the Longitudinal Aging Study Amsterdam
A. Braam, J. Schaap Jonker, M. van der Horst, B. Steunenberg, A. Beekman, W. van Tilburg, D. Deeg (The Netherlands)
RS60.4 Understanding Geetopdesh: enhancing skills in the practice of psychotherapy
M. Sameer (India)
| 14.45-16.15 | Regular Symposium RS61 |
USING NEUROENDOCRINOLOGY TO UNDERSTAND PATHOGENESIS AND DEVELOP NEW TREATMENTS
Chairperson: A. Shrivastava (Canada)
RS61.1 The effect of early life trauma on the corticotropin-releasing factor circuits: implications for the pathophysiology and treatment of mood and anxiety disorders
C.B. Nemeroff (USA)
RS61.2 Neuropeptides in schizophrenia: focus on environmental risk factors
A. Shrivastava (Canada)
RS61.3 Cortisol in depressive subtypes: status of glucocorticoid antagonists
A.F. Schatzberg (USA)
RS61.4 Nonhuman primate models to study HPA and CRF dysregulation in anxiety and depression
N.H. Kalin (USA)
RS61.5 Update on regulation of the HPA axis: focus on cognitive and neurobiological approaches
G. Tafet (Argentina)
| 14.45-16.15 | Regular Symposium RS62 |
CURRENT RESEARCH IN TRANSCULTURAL PSYCHIATRY IN THE UNITED STATES
Chairpersons: J. Boehnlein (USA), R. Kohn (USA)
RS62.1 Research in cultural psychiatry in the United States over the last ten years
R. Kohn, R. Wintrob (USA)
RS62.2 Adapting multifamily groups to improve treatment adherence in Latinos with schizophrenia
A. Kopelowicz (USA)
RS62.3 “Sociocultural issues” in psychiatry residency training accreditation standards in the United States: present and future
F. Lu (USA)
RS62.4 To be or not to be? Cultural components in the development of DSM-5
R. Alarcón (USA)
RS62.5 A cross-national multi-center study of depression, demoralization and functional impairment in cancer patients
J.M. de Figueiredo (USA)
| 14.45-16.15 | Regular Symposium RS63 |
RECENT TRENDS AND HOT ISSUES CONCERNING PSYCHIATRIC TRAINING AND EARLY PHASES OF PSYCHIATRIC CAREER
Chairpersons: U. Volpe (Italy), N. Jovanovic (Croatia)
RS63.1 Leadership, role and administrative issues in early phases of psychiatric career
J.N. Beezhold (UK)
RS63.2 Learning to lead multidisciplinary teams: lessons for young psychiatrists
A. Malik (UK)
RS63.3 Well-being and mental health of psychiatry residents
N. Jovanovic (Croatia)
RS63.4 The challenges of psychiatric training in low- and middle-income countries: a focus on Latin America
G. Rivera (Bolivia)
RS63.5 Development and future perspectives of European young psychiatrists
D. Giacco, A. Fiorillo, U. Volpe (Italy)
| 14.45-16.15 | Workshop WO11 |
DEALING WITH THE MENTAL HEALTH CONSEQUENCES OF THE EAST JAPAN DISASTER
K. Matsumoto, T. Akiyama, Y. Suzuki, Y. Kim (Japan)
| 14.45-16.15 | Section Symposium SS36 |
INTEGRATING APPROACHES TO MENTAL HEALTH PROMOTION AND PREVENTION (organized by the WPA Section on Preventive Psychiatry)
Chairpersons: N. Christodoulou (UK/Greece), R. Jenkins (UK)
SS36.1 Mental capital and wellbeing: encouraging governments to place mental health promotion and prevention at the heart of general government policy
R. Jenkins (UK)
SS36.2 Culture, ethics and preventive psychiatry in South Asia
R.A. Kallivayalil (India)
SS36.3 Strengthening resilience: an aim of prevention and health promotion
M. Schmolke (Germany)
SS36.4 Prevention of non-promotion of prevention and promotion: the situation in psychiatric and medical training
N. Christodoulou (UK/Greece)
| 14.45-16.15 | Section Symposium SS37 |
TOWARDS ICD-11 AND DSM-5 CLASSIFICATIONS OF MENTAL DISORDERS: NEW OPPORTUNITIES FOR OLD AGE ISSUES AND SPECIFICITIES? (organized by the WPA Section on Old Age Psychiatry)
Chairpersons: V. Camus (France), G. Stoppe (Switzerland)
SS37.1 New diagnostic criteria for Alzheimer's disease and dementia with Lewy bodies: are they an advance over current criteria?
J. O’Brien (UK)
SS37.2 Alzheimer's disease and related disorders: why and how should they be maintained in the DSM-5 and ICD-11 classifications?
V. Camus (France)
SS37.3 DSM-5/ICD 11: a new opportunity to clarify the diagnostic criteria for late onset psychotic disorders?
L. Aguera-Ortiz (Spain)
SS37.4 Including an old age psychiatry perspective in ICD-11
A. Von Gunten (Switzerland)
SS37.5 DSM-5 and its relationship to old age psychiatry
D. Jeste (USA)
| 14.45-16.15 | Section Symposium SS38 |
CULTURE AND HUMAN SEXUALITY (organized by the WPA Section on Psychiatry and Human Sexuality)
Chairpersons: S. Azim (Egypt), A. Palha (Portugal)
SS38.1 Culture and human sexuality: an Egyptian and African perspective
S. Azim (Egypt)
SS38.2 A short survey on sexual educations of Maputo late adolescents: values, attitudes and behaviors
A. Palha, A. Ratilal (Portugal)
SS38.3 Culture and sexual health
R. Hernandez (Venezuela)
SS38.4 Online sexual preferences
C. Simonelli, K. Wylie (Italy/UK)
| 14.45-16.15 | Section Symposium SS39 |
OCCUPATIONAL PSYCHIATRY IN 2011: ITS PAST AND ITS FUTURE
(organized by the WPA Section on Occupational Psychiatry)
Chairperson: J. Metzer (Australia)
SS39.1 Occupations in the past and future: intersections of mental health, stress and wellbeing
J. Metzer (Australia)
SS39.2 Recent mental health problems in Japanese working place: overwork and suicide
T. Maruta, C. Matsumoto, M. Iimori (Japan)
SS39.3 Occupational psychiatry in search of its proper role: the case of Italy
G. Pozzi, A. Frustaci, I. Borrelli, M. Di Giannantonio (Italy)
SS39.4 Employee fitness for sensitive positions: what roles for treating and occupational clinicians?
R. Schouten (USA)
SS39.5 Common occupational hazards encountered in international postings
A. Lau (UK)
SS39.6 Occupational stressors and gender differences: past and present
A.M. Rossi (Brazil)
SS39.7 Occupational stress, burnout syndrome and hardiness among civilian and military teachers
L.A.M. Guimarães, H.P. Vieira (Brazil)
| 14.45-16.15 | Section Symposium SS40 |
ADOLESCENTS: ARE THEY A RISK GROUP FOR SUICIDE?
(organized by the WPA Section on Suicidology)
Chairpersons: D. Wasserman (Sweden), A. Roy (USA)
SS40.1 Global trends of youth suicide in urban and rural regions
G. Caracci (USA)
SS40.2 Saving and empowering young lives in Europe (SEYLE): design and method
D. Wasserman (Sweden)
SS40.3 Suicidal behaviour among adolescents in Europe: results from the SEYLE project
M. Sarchiapone (Italy)
SS40.4 Internet and media-based suicide prevention: the SUPREME project
V. Carli (Sweden)
SS40.5 School-based awareness programme in the EU projects SEYLE and WE-STAY
C. Wasserman (USA)
| 14.45-16.15 | Simposio Regular RSp/e41 |
TDAH NO TRATADO EN ADULTOS: TRASTORNOS DE PERSONALIDAD, DROGAS Y PRISIÓN
Presidente: F. Pérez Arnau (España)
RSp/e41.1 TDAH, trastornos de personalidad y trastornos por uso de substancias:
trimorbilidad emergente
M. Ferrer Vinardell (España)
RSp/e41.2 TDAH en medio penitenciario
O. Sanz García (España)
RSp/e41.3 Tratamiento del TDAH en adultos
J.A. Ramos-Quiroga (España)
| 14.45-16.15 | Simposio Regular RSp/e42 |
EFECTOS TERAPEUTICOS DE LOS DISPOSITIVOS GRUPALES
Presidente: L. Edelman (Argentina)
RSp/e42.1 El grupo de reflexión como instrumento de abordaje de problemáticas
psicosociales
D. Kordon (Argentina)
RSp/e42.2 El grupo de medicación
B. Linne (Argentina)
RSp/e42.3 Prevención de la violencia de género con técnicas psicodramáticas en
grupos de hombres y mujeres
E. Stola (Argentina)
RSp/e42.4 El lugar del coordinador de grupo terapéutico
N. Sakalik (Argentina)
| 14.45-16.15 | Simposios Regulares RSp/e43 |
EN LOS LÍMITES DE LA PSIQUIATRÍA FORENSE: LA VIOLENCIA EXTREMA
Presidente: N.R. Stingo (Argentina)
RSp/e43.1 Proclividad a la violencia extrema
N. Stingo (Argentina)
RSp/e43.2 Análisis médicolegal de la violencia extrema
R. Godoy (Argentina)
RSp/e43.3 Filicidio: madres que matan a sus hijos
M. Zazzi (Argentina)
RSp/e43.4 Criminalidad serial
J. Verduci (Argentina)
| 14.45-16.15 | Simposios Regulares RSp/e44 |
NUEVOS APORTES EN EL TRATAMIENTO INTEGRAL DEL JUEGO PATOLÓGICO
Presidente: M. Tome (Argentina)
RSp/e44.1 La recaída dentro del proceso terapéutico de la ludopatía
J.A. Brizuela (Argentina)
RSp/e44.2 Tratamiento multimodal residencial breve en jugadores patológicos
C. Sánchez Bello (Venezuela)
RSp/e44.3 Terapia familiar sistémica en los jugadores patológicos
M. del P. Jaime Izquierdo (Colombia)
RSp/e44.4 El rol de las cogniciones en el abordaje cognitivo conductual
M. Tome (Argentina)
| 16.30-18.00 | KEYNOTE LECTURES |
Chairperson: F. Kigozi (Uganda)
KL17 Advances in the understanding and treatment of addictive disorders
C.P. O'Brien (USA)
KL18 The indelible lessons of trauma: the propensity to remember and forget
A.C. McFarlane (Australia)
| 16.30-18.00 | Regular Symposium RS64 |
CURRENT FACTS AND TRENDS IN THE TREATMENT OF SCHIZOPHRENIA
Chairperson: V. Larach-Walters (Chile)
RS64.1 Response rates for different dimensions of psychosis: future developments
W. Gaebel (Germany)
RS64.2 Why are “depots” back?
V. Larach-Walters (Chile)
RS64.3 Social capital, pathway to care and duration of untreated psychosis: findings from a low and middle income country context
J.K. Burns, J.B. Kirkbride, K. Jhazbhay, R.A. Emsley (South Africa/UK)
RS64.4 Time to antipsychotic response: when to consider a patient refractory and what to do
H. Elkis (Brazil)
| 16.30-18.00 | Regular Symposium RS65 |
PRESENT AND CLOSE FUTURE OF ALZHEIMER’S DISEASE TREATMENT
Chairperson: J.-M. Orgogozo (France)
RS65.1 Clinical practice with anti-dementia drugs: revised consensus
J.T. O'Brien (UK)
RS65.2 Safety considerations on magnetic resonance imaging in anti-amyloid trials: a review
P. Scheltens (The Netherlands)
RS65.3 Development of passive immunotherapy: limitations and chances
C. Hock (Switzerland)
RS65.4 Active anti-amyloid immunotherapy in Alzheimer’s disease with CAD 106
J.-M. Orgogozo (France)
| 16.30-18.00 | Regular Symposium RS66 |
IMMUNE-MEDIATED BODY-MIND INTERACTIONS IN MOOD DISORDERS: DIAGNOSTIC AND THERAPEUTIC PERSPECTIVES
Chairpersons: A.M. Myint (Germany), A. Halaris (USA)
RS66.1 The diagnostic and prognostic value of monocyte gene expression and T cell phenotypic profiles in mood disorders
H.A. Drexhage, R.C. Drexhage, K. Weigelt, E. Mesman, M. Hillegers, L. Carvalho, V. Bergink, W.A. Nolen (The Netherlands)
RS66.2 Autonomic nervous system and immune interaction in depression
A. Halaris (USA)
RS66.3 Biochemical and genetic aspects of immune and kynurenine markers in mood disorders
A.M. Myint, M. Rothermundt, M.J. Schwarz, M. Muelbacher, S. Claes (Germany/Austria/Belgium)
RS66.4 Post-mortem studies on the role of microglia in depression: is there evidence for a cerebral activation of the mononuclear phagocyte system?
J. Steiner, A.M. Myint (Germany)
| 16.30-18.00 | Regular Symposium RS67 |
MENTAL ILLNESSES IN TRADITIONAL SOCIETIES: CULTURE SPECIFIC OR CULTURAL VARIANTS?
Chairpersons: S. Malik (India), S. Malhotra (India)
RS67.1 Ancient civilization concepts of mental health and illness
V. Varma (USA)
RS67.2 Relationship between acute psychosis and schizophrenia: evidence from research
S. Malhotra, S. Malhotra (India)
RS67.3 The semantics, syntactics, and pragmatics of culture specificity and boundedness
N. Gupta (UK)
RS67.4 Does Dhat syndrome convey anything meaningful?
S. Malik, N. Ahuja (India/UK)
| 16.30-18.00 | Workshop WO12 |
INTERNATIONAL STUDY OF PATIENT EXPERIENCES OF IN-PATIENT PSYCHIATRIC CARE: THE IDEA PROJECT
G. Thornicroft, N. Sartorius, D. Rose, N. Mehta, E. Malcolm, A. Dickens, F. Mammadova (UK/Switzerland/Uganda/Azerbaijan), for the IDEA Study Group
| 16.30-18.00 | Workshop WO13 |
YOUNG PATIENTS AND TODAY TREATMENTS: ALLIANCE BETWEEN PSYCHIATRY AND PSYCHOANALYSIS
M. Ammon, M. Schmolke, M. Botbol, J. Bartolomei (Germany/Switzerland/France)
| 16.30-18.00 | Section Symposium SS41 |
INDEPENDENT MEDICAL EXAMINATIONS (organized by the WPA Section on Forensic Psychiatry)
Chairperson: J. Taborda (Brazil)
SS41.1 Independent forensic-psychiatric examinations in Germany
N. Konrad (Germany)
SS41.2 Independent medical examinations in Canada
J. Arboleda-Florez (Canada)
SS41.3 Independent forensic-psychiatric examinations in Brazil
J. Taborda (Brazil)
SS41.4 Forensic hospitals in Brazil and the practice of forensic psychiatry
E. Abdalla-Filho (Brazil)
| 16.30-18.00 | Section Symposium SS42 |
CHALLENGES OF MOOD DISORDERS: FROM DIAGNOSIS TO TREATMENTS (organized by the WPA Section on Affective Disorders)
Chairperson: S.V. Parikh (Canada)
SS42.7 Latent class analysis of manic and depressive symptoms in a population-based sample in São Paulo, Brazil
D.H. Moreno, L.H. Andrade (Brazil)
SS42.2 Antidepressants and bipolar disorders
G.H. Vázquez (Argentina)
SS42.3 Deep brain stimulation to the subcallosal cingulate gyrus for treatment resistant depression: an update
S.H. Kennedy (Canada)
SS42.4 Validity and utility of internet cognitive-behavioural therapy for depression
S.V. Parikh (Canada)
| 16.30-18.00 | Section Symposium SS43 |
EDUCATION PROGRAMS FOR PREVENTION OF SUICIDE
(organized by the WPA Section on Education in Psychiatry)
Chairpersons: B. Coskun (Turkey), B. Sadock (USA)
SS43.1 Patient suicide: implications for training
B. Sadock (USA)
SS43.2 Disseminating training for suicide prevention: the STORM initiative in the UK
L. Gask (UK)
SS43.3 Suicide and suicidal attempts: education of the community
D. Moussaoui (Morocco)
SS43.4 Suicide risk assessment: outcomes of the Norwich training program
J. Beezhold, E. Sutton (UK)
SS43.5 Results of a suicide decreasing program in the Tomsk region
N. Kornetov (Russia)
SS43.6 Prevention of adolescent suicide in Italy: the Amico Charley Foundation
D. Baron (USA)
SS43.7 Educational aspects of a case discussion program with crisis intervention teams of general hospitals at Kocaeli, Turkey
B. Coskun (Turkey)
| 16.30-18.00 | Section Workshop SW3 |
NEW PERSPECTIVES IN APPROACHING DISASTER PSYCHIATRY INTERVENTIONS (organized by the WPA Section on Disaster Psychiatry)
R. D’Souza, M. Benyakar, J. Thome, J.T. Balseiro Estevez, N. Prieto (Australia/Argentina/Brazil/Haiti/France)
| 16.30-18.00 | Oral Communication Session OC19 |
PSYCHIATRY AND GENERAL MEDICINE (III)
| 16.30-18.00 | Simposio Regular RSp/e45 |
EL TRASTORNO BIPOLAR PEDIATRICO Y SU EXPRESIÓN CLÍNICA EN LATINOAMERICA
Presidente: L. Viola (Uruguay)
RSp/e45.1 El trastorno bipolar pediátrico. Complejidades en el uso de la Child
Behavior Checklist – CBCL como complemento diagnóstico
L. Viola (Uruguay)
RSp/e45.2 Desregulación severa del humor, entre el TDAH y la bipolaridad infantil
A. Abadi (Argentina)
RSp/e45.3 Escolaridad y funciones cognitivas en niños y adolescentes con trastorno
bipolar
R. Chamorro (Chile)
RSp/e45.4 El recurso farmacológico en el trastorno bipolar en niños y adolescentes
R. Pallia (Argentina)
| 16.30-18.00 | Simposio Regular RSp/e46 |
ESTUDIOS GENÉTICOS Y DE FARMACOGENÓMICA EN AMÉRICA LATINA
Presidente: H. Silva (Chile)
RSp/e46.1 Estudio clínico y genético de pacientes con trastorno límite de
personalidad y pacientes bipolares II
H. Silva (Chile)
RSp/e46.2 Endofenotipos en el TOC
H. Nicolini (Méjico)
RSp/e46.3 Estudios genéticos de dimensiones sintomáticas y endofenotipos en
esquizofrenia y trastorno bipolar
J. Ospina Duque (Colombia)
RSp/e46.4 Farmacogenómica psiquiátrica: promesas de desarrollo y perspectivas
R.D. Alarcón (Perú)
| 16.30-18.00 | Simposio Regular RSp/e47 |
TENDENCIAS ACTUALES DE LA INVESTIGACIÓN EN PSIQUIATRÍA CULTURAL
Presidente: F. Collazos (España)
RSp/e47.1 El ensayo clínico: estudio sobre la efectividad y la tolerabilidad de
la duloxetina en el tratamiento de los trastornos depresivos mayores
en minorías étnicas
F. Collazos (España)
RSp/e47.2 El modelo clínico-epidemiológico: factores determinantes de patología
mental reactiva en población inmigrante. Una comparativa con respecto
a la población autóctona
S. Bermann (España)
RSp/e47.3 El método etnográfico cualitativo: fenómenos disociativos leves en
casamance, sur de Senegal
D. Berenstein (Argentina)
| 16.30-18.00 | Simposio Regular RSp/e48 |
TRASTORNOS DE LA CONDUCTA ALIMENTARIA: TERAPÉUTICA EN POBLACIONES ESPECIALES
Presidente: H. Bertera (Argentina)
RSp/e48.1 Trastornos de la conducta alimentaria y embarazo
H. Bertera (Argentina)
RSp/e48.2 Trastornos de la conducta alimentaria y enfermedad metabólica
M.E. Strada (Argentina)
RSp/e48.3 Trastornos de la conducta alimentaria en niños
A. Oliva (Argentina)
RSp/e48.4 Trastornos de la conducta alimentaria y transmisión transgeneracional
L. Mato (Argentina)
| 18.15-19.45 | Core Symposium CS12 |
SOCIAL BRAIN AND SOCIAL COGNITION
Chairperson: R.I.M. Dunbar (UK)
CS12.1 The social brain and its cognitive implications: evolution meets everyday behaviour
R.I.M. Dunbar (UK)
CS12.2 Social selection and the origins of morality and social anxiety
R.M. Nesse (USA)
CS12.3 Reconciling ‘the new epidemiology’ with an evolutionary genetic basis for schizophrenia
J.K. Burns (South Africa)
| 18.15-19.45 | Core Symposium CS13 |
IMPROVING QUALITY OF MENTAL HEALTH SERVICES
Chairperson: R. Jenkins (UK)
CS13.1 Improving the quality of care in psychiatric wards
P. Lelliott (UK)
CS13.2 Reducing the know-do gap in community mental health services
A. Alem (Ethiopia)
CS13.3 Integrating mental health into primary care: why psychiatric leadership is essential for implementation
R. Jenkins (UK)
| 18.15-19.45 | Regular Symposium RS68 |
CANADIAN NETWORK FOR MOOD AND ANXIETY TREATMENTS (CANMAT) BIPOLAR DISORDER GUIDELINES: A CONSTANT EVOLUTION
Chairpersons: L. Yatham (Canada), R. Milev (Canada)
RS68.1 CANMAT guidelines for evidence based management of mania
L. Yatham (Canada)
RS68.2 CANMAT guidelines for the management of bipolar I depression
A. Schaffer (Canada)
RS68.3 The management of bipolar II disorder: new advances in treatment
D. Bond (Canada)
RS68.4 Treatment of comorbidity in individuals with major depressive disorder or bipolar disorder: therapeutic approaches to the “real world” patient
R. McIntyre (Canada)
| 18.15-19.45 | Regular Symposium RS69 |
RELATIONSHIP OF STIGMA, NEEDS AND INFORMAL CARE TO OUTCOME OF SEVERE SCHIZOPHRENIC DISORDERS: THE MARISTAN STUDY
Chairperson: F. Torres-González (Spain)
RS69.1 The MARISTAN study. Phase I: the qualitative approach
F. Torres-González, A. Runte Geidel, C. Antonioli, J.M. Caldas de Almeida, M.B. King (Spain/Argentina/Portugal/UK)
RS69.2 MARISTAN scale for stigma in people that suffer from schizophrenia and related disorders: psychometric properties
S. Saldivia, M. King, F. Torres, M. Xavier, C. Antonioli, D. Ballester, A. Runte, P. Grandon, R. Melipillan (Chile/UK/Spain/Portugal/Argentina/Brazil)
RS69.3 MARISTAN scale for needs and informal care in people that suffer from schizophrenia and related disorders: psychometric properties
D. Ballester, C. Antonioli, P. Grandon, M. King, A. Runte, S. Saldivia, F. Torres, M. Xavier, R. Melipillan (Brazil/Argentina/Chile/UK/Spain/Portugal)
RS69.4 Relationship of stigma, needs and informal care to outcome of severe schizophrenic disorders: design of phase III of MARISTAN study
B. Vicente, D.A. Ballester, J.M. Caldas de Almeida, E. Galende, M.B. King, S. Saldivia, F. Torres-González (Chile/Brazil/Portugal/Argentina/UK/Spain)
| 18.15-19.45 | Regular Symposium RS70 |
RESILIENCE AND VULNERABILITY FACTORS IN DEPRESSION: IMPLICATIONS FOR THERAPEUTIC INTERVENTIONS
Chairpersons: E. Holsboer-Trachsler (Switzerland), E. Arzt (Argentina)
RS70.1 Neuroendocrine molecular regulation of stress, anxiety and depression
E. Arzt (Argentina)
RS70.2 Brain-derived neurotrophic factor: state of the art in depression and prediction of therapy response
A. Eckert (Switzerland)
RS70.3 Neuroendocrine and sleep regulation as predictors of healthy mental development in children and predictors of course of depression in adults
M. Hatzinger (Switzerland)
RS70.4 Seeking for new targets and circuits in depression: from molecular screenings to in vivo genetic dissection in mutant mice
D. Refojo (Germany)
| 18.15-19.45 | Regular Symposium RS71 |
THE ALEXITHYMIA CONSTRUCT: HISTORY, RECENT DEVELOPMENTS AND FUTURE DIRECTIONS
Chairperson: G.J. Taylor (Canada)
RS71.7 An overview of alexithymia
G.J. Taylor (Canada)
RS71.2 Alexithymia: from theory to clinical practice
H.A. Lunazzi (Argentina)
RS71.3 Alexithymia, personality, and the DSM-5
R.M. Bagby (Canada)
RS71.4 Perspectives on the future of alexithymia research based on recent fMRI and self-report alexithymia investigations
G. Komaki (Japan)
| 18.15-19.45 | Regular Symposium RS72 |
MENTAL HEALTH CARE IN THE BALKANS AND EASTERN EUROPE
(organized by the Psychiatric Association for Eastern Europe and the Balkans)
Chairpersons: G.N. Christodoulou (Greece), D. Lecic-Tosevski (Serbia)
RS72.1 Towards reform of psychiatry and psychiatrists
D. Lecic-Tosevski (Serbia)
RS72.2 Toward reform of mental health services in Turkey
P.G. Gökalp, F. Karadag, A.G. Hariri, O. Saatcioglu, B. Aslantas, E. Ertekin (Turkey)
RS72.3 Mental health care provision in Greece: the unfinished reform
G.N. Christodoulou, D.N. Ploumpidis, N.G. Christodoulou, D. Anagnostopoulos (Greece)
RS72.4 Advances and restrictions of psychiatric reform in Russia
V. Krasnov (Russia)
| 18.15-19.45 | Workshop WO14 |
FUNCTIONAL SOMATIC COMPLAINTS AS MANIFESTATION OF DEPRESSION: EXPERIENCE FROM INDIA
A. Avasthi, E. Mohandas, S. Grover (India)
| 18.15-19.45 | Section Symposium SS44 |
PARENT AND INFANT MENTAL HEALTH: BOTH PARENT AND INFANT ARE ESSENTIAL! (organized by the WPA Section on Perinatal Psychiatry and Infant Mental Health)
Chairpersons: N. Garret-Gloanec (France), G. Apter (France)
SS44.1 Can self-report scales (including the Edinburgh Postnatal Depression Scale) reliably be used to assess the mother-infant dyad?
J. Cox (UK)
SS44.2 Assessment and care during the pre-partum: post-partum impact
G. Apter (France)
SS44.3 Management of parent-infant treatment
M. Keren (Israel)
| 18.15-19.45 | Section Symposium SS45 |
INFORMATICS AND TELECOMMUNICATIONS IN PSYCHIATRY
(organized by the WPA Section on Informatics and Telecommunications in Psychiatry)
Chairperson: R. Hsiung (USA)
SS45.1 Predicting who will benefit from online support groups
R. Hsiung (USA)
SS45.2 Online professional communication in the age of Facebook and YouTube
F. Bollorino (Italy)
SS45.3 Compulsive Internet use: is it really an addiction?
R. Rosenthal (USA)
SS45.4 Pathological use of Internet: pro-anorexia web sites
P.M. Furlan, S. Corio, F. Oliva, L. Ostacoli, R.L. Picci (Italy)
| 18.15-19.45 | Section Symposium SS46 |
NEW DATA ON ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
(organized by the WPA Section on Attention Deficit Hyperactivity Disorders)
Chairperson: I. Manor (Israel)
SS46.1 A three-year longitudinal prevalence study of ADHD: findings from Turkey
E. Ercan (Turkey)
SS46.2 Metadoxine: a novel non-stimulant extended-release drug for treating ADHD
I. Manor, Y. Daniely, D. Megiddo, R Yamin, A. Weizman (Israel)
SS46.3 Reward related striatal activation is influenced by nitric oxide synthetase genotype in ADHD patients and healthy controls
J.K. Buitelaar, M. Hoogman, B. Franke (The Netherlands)
SS46.4 Descriptive epidemiology, clinical presentation and response to methylphenidate administration in a clinical sample of preschool children in Israel
M. Peskin, S. Rozen, S. Spitzer, I. Manor (Israel)
| 18.15-19.45 | Section Symposium SS47 |
GLOBALIZATION AND ECOLOGICAL CHANGES: EFFECTS ON MENTAL HEALTH (organized by the WPA Sections on Ecology, Psychiatry and Mental Health, on Conflict Management and Resolution, and on Psychiatry in Developing Countries)
Chairpersons: L. Janiri (Italy), A. Javed (UK)
SS47.1 Ecological changes and effects on mental health: perspectives from developing countries
A. Javed (UK)
SS47.2 Environmental challenges and mental health: the Caribbean experience
F.W. Hickling (Jamaica)
SS47.3 The effects of globalization on mental health
M. Kastrup (Denmark)
SS47.4 From sensitivity to climate and weather changes to meteoropathic disorders: a dimensional psychopathology?
L. Janiri, M. Mazza, M. Di Nicola, V. Catalano, D. Harnic, G. Spinetti (Italy)
| 18.15-19.45 | Simposio Regular RSp/e49 |
PROGRAMA DE TERAPIA COGNITIVA PARA PERSONAS CON ESCASOS RECURSOS SOCIO ECONÓMICOS
Presidente: B. Gómez (Argentina)
RSp/e49.1 Presentación del programa P.A.T.E.R
B. Gómez (Argentina)
RSp/e49.2 Admisión y evaluación
M. Maristany (Argentina)
RSp/e49.3 Aplicación clínica e ilustración de casos
A. Pérez (Argentina)
RSp/e49.4 Programas de tratamiento en contextos clínicos institucionales
E. Vega (Argentina)
| 18.15-19.45 | Simposio Regular RSp/e50 |
NEUROCIENCIAS, PSIQUIATRÍA, PISICOANÁLISIS Y ADICCIONES: CREANDO PUENTES
Presidente: N. Feldman (Suiza)
RSp/e50.1 La clínica de las adicciones entre el psicoanálisis y las neurociencias
N. Feldman (Suiza)
RSp/e50.2 Tercera tópica: un modelo psicoanalítico freudiano de la mente y su
articulación con las neurociencias
R. Zukerfeld (Argentina)
RSp/e50.3 La adicción, un trastorno de excesiva automatización
D. Zullino (Suiza)
| 18.15-19.45 | Simposio Regular RSp/e51 |
NEUROSPECT Y DIAGNÓSTICO EN PSIQUIATRÍA
Presidente: E. Galli (Perú)
RSp/e51.1 10 años de SPECT cerebral: una revisión de la imagen resultados
de psiquiatría
E. Galli (Perú)
RSp/e51.2 NeuroSPECT en el diagnóstico psiquiátrico. Esquizofrenia y trastornos
de la personalidad
I. Mena (Chile)
RSp/e51.3 NeuroSPECT en el diagnóstico psiquiátrico. Trastornos del estado de
ánimo: trastorno bipolar y depresión mayor
A. Nader (Chile)
RSp/e51.4 SPECT cerebral y trastorno cognoscitivo
F. Mena (Chile)
| 18.15-19.45 | Simposio Regular RSp/e52 |
CONFLUENCIAS EN EL CAMPO ACTUAL DE LAS PSICOTERAPIAS
Presidente: R. Rocca (Argentina)
RSp/e52.1 Las tendencias a la confluencia en el siglo XXI
R. Rocca (Argentina)
RSp/e52.2 Consideraciones actuales sobre la empatía
A. Patiño (Argentina)
RSp/e52.3 La persona del terapeuta en la formación profesional
S. Jajam (Argentina)
RSp/e52.4 Obstáculos y dificultades para la integración
I. Barreira (Argentina)